5-Fluoro-N-(piperidin-4-yl)pyrimidin-2-amine dihydrochloride, 1g

7-Trifluoromethoxyisatin, 95.0%, 250mg

5,6,7,8-Tetrahydronaphthalene-1-carboxylic acid, 97.0%, 1g

Monohidrato de 1,10-fenantrolina, mínimo 99 %, pa, ACS, 25 g, envase de vidrio

(S)-1,2-Diaminopropane-N,N,N',N'-tetraacetic acid, 95.0%, 250mg

2-Iodo-1-(2,2,2-trifluoroethyl)-1H-indol-4-amine, 98%, 1g

4-Bromo-2-fluoro-5-nitrophenol, 95.0%, 1g

3-(4-Nitro-pyrazol-1-yl)-propionitrile, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane, 95.0%, 1g

2-Amino-5-(trifluoromethyl)-1,3,4-thiadiazole, 97.0%, 1g

Trimethyl-beta-cyclodextrin>98.0%(HPLC)1g

4-Benzyl-2-hydroxymorpholin-3-one, 95.0%, 100g

3-BROMO-2-(FLUOROMETHYL)-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg